Back to Search Start Over

Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan.

Authors :
Kageyama, Susumu
Okinaka, Yuki
Nishizawa, Koji
Yoshida, Toru
Ishitoya, Satoshi
Shichiri, Yasumasa
Kim, Chul Jang
Iwata, Tsuyoshi
Yokokawa, Ryusei
Arai, Yutaka
Nishikawa, Zenkai
Soga, Hiroki
Ushida, Hiroshi
Sakano, Yuji
Naya, Yoshio
Wada, Akinori
Nagasawa, Masayuki
Yoshida, Tetsuya
Narita, Mitsuhiro
Kawauchi, Akihiro
Source :
Molecular & Clinical Oncology. Jan2023, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

Prostate cancer is the most common genitourinary cancer in men. Population-based serum prostate-specific antigen (PSA) testing is used to screen men for the early detection of asymptomatic prostate cancer. The present study compared the features of patients with prostate cancer in Kusatsu City, the only municipality in Shiga Prefecture of Japan to implement organized PSA screening, with those in other municipalities. The target population for organized PSA screening by mail invitation was men ≥50 years. Patients were pathologically diagnosed via prostate biopsy because of elevated serum PSA. This multicenter observational study was subsequently conducted in 14 hospitals. The following information was extracted from patient records: age, reason for PSA testing, initial PSA level, Gleason score, clinical stage, and place of residence. Risk classification was defined as low, intermediate, high, and advanced. Each patient was stratified according to their city/town. A total of 984 patients diagnosed with prostate cancer in Shiga in 2012 and 2017 were analyzed, of which 955 (97%) were opportunistically tested, with the remaining 29 (3%) assessed by organized screening. In Kusatsu, 93 patients were diagnosed, of whom 26 (28%) were detected by organized screening. By contrast, only three of 891 patients (0.3%) were detected by organized screening in other municipalities. Of patients in Kusatsu, cases identified by opportunistic testing had a higher initial PSA value (P=0.010) than those identified by organized screening. However, patients detected through opportunistic testing in Kusatsu City were younger (P=0.034), had a lower PSA value (P=0.001), and improved risk classification (P<0.001) than those in other municipalities. It was concluded that more patients were diagnosed with early-stage cancer by organized PSA screening. Furthermore, population-based PSA screening in Kusatsu City may have indirectly affected early detection, even by opportunistic testing. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20499450
Volume :
18
Issue :
1
Database :
Academic Search Index
Journal :
Molecular & Clinical Oncology
Publication Type :
Academic Journal
Accession number :
161113138